{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:04:47Z","timestamp":1791493487138,"version":"4.3.4"},"reference-count":157,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009232","name":"Debreceni Egyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024601","name":"University of Debrecen Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtauto.2026.100366","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T09:35:08Z","timestamp":1773912908000},"page":"100366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Autoantibodies in the diagnostics, prognostics and follow-up of primary biliary cholangitis"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9246-726X","authenticated-orcid":false,"given":"P\u00e9ter","family":"Antal-Szalm\u00e1s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra","family":"Bencze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarolta","family":"Demeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"P\u00e9nzes-Daku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilla","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3za","family":"F\u00f6ldesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtauto.2026.100366_bib1","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/ajg.2015.312","article-title":"Changing nomenclature for PBC: from \u2018Cirrhosis\u2019 to \u2018Cholangitis\u2019","volume":"110","author":"Beuers","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib2","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jtauto.2026.100366_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0034-1383731","article-title":"The natural history of primary biliary cirrhosis","volume":"34","author":"Imam","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","article-title":"American association for study of liver diseases, primary biliary cirrhosis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib5","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.3390\/jcm10194551","article-title":"Real-world management of patients with primary biliary Cholangitis-A retrospective study from a tertiary medical center in Israel","volume":"10","author":"Yehezkel","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis","volume":"16","author":"You","year":"2022","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jtauto.2026.100366_bib7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/jgh.15329","article-title":"Regional variation and temporal trend of primary biliary cholangitis epidemiology: a systematic review and meta\u2010analysis","volume":"36","author":"Lv","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib8","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3748\/wjg.v29.i12.1795","article-title":"Role of autoantibodies in the clinical management of primary biliary cholangitis","volume":"29","author":"Rigopoulou","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jtauto.2026.100366_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/liv.12434","article-title":"The Epi PSC PBC study group, rising incidence and prevalence of primary biliary cirrhosis: a large population\u2010based study","volume":"34","author":"Boonstra","year":"2014","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100366_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0034-1383730","article-title":"The new epidemiology of primary biliary cirrhosis","volume":"34","author":"Griffiths","year":"2014","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib13","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.15214","article-title":"Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence and significance for clinical presentation and disease outcome","volume":"36","author":"Efe","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib14","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5009\/gnl16365","article-title":"Extrahepatic manifestations of primary biliary cholangitis","volume":"11","author":"Chalifoux","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.jtauto.2026.100366_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2007-1007183","article-title":"Antimitochondrial antibodies in primary biliary cirrhosis","volume":"17","author":"Leung","year":"1997","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib16","article-title":"Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis","volume":"9","author":"Hu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2026.100366_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2249.2002.01719.x","article-title":"Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders","volume":"127","author":"Muratori","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jtauto.2026.100366_bib18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/15321819.2012.741088","article-title":"Detection of anti-SP100 antibodies in primary biliary cirrhosis. Comparison of ELISA and immunofluorescence","volume":"34","author":"Bauer","year":"2013","journal-title":"J. Immunoassay Immunochem."},{"key":"10.1016\/j.jtauto.2026.100366_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib20","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hep.21678","article-title":"Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis","volume":"45","author":"Bogdanos","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jtauto.2026.100366_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib23","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.14309\/ajg.0000000000000690","article-title":"Novel anti-hexokinase 1 antibodies are associated with poor prognosis in patients with primary biliary cholangitis","volume":"115","author":"Reig","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib24","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/liv.12690","article-title":"Anti\u2010kelch\u2010like 12 and anti\u2010hexokinase 1: novel autoantibodies in primary biliary cirrhosis","volume":"35","author":"Norman","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100366_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2022.914505","article-title":"A review on biomarkers for the evaluation of autoimmune cholestatic liver diseases and their overlap syndromes","volume":"2","author":"Nguyen","year":"2022","journal-title":"Front. Mol. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10238-012-0207-4","article-title":"Clinical significance and prevalence of anti-Saccharomyces cerevisiae antibody in Chinese patients with primary biliary cirrhosis","volume":"13","author":"Hu","year":"2013","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1517\/17530059.2.6.621","article-title":"Molecular diagnostics of primary biliary cirrhosis","volume":"2","author":"Rigopoulou","year":"2008","journal-title":"Expert Opin. Med. Diagn."},{"key":"10.1016\/j.jtauto.2026.100366_bib28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2036.2007.03433.x","article-title":"Antibodies to SS\u2010A\/Ro\u201052kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis","volume":"26","author":"Granito","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jtauto.2026.100366_bib29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jalm\/jfab099","article-title":"The role of autoantibodies in the diagnosis of autoimmune liver disease: lessons learned from clinical practice","volume":"7","author":"Van Beers","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2017-315259","article-title":"The British society of Gastroenterology\/UK-PBC primary biliary cholangitis treatment and management guidelines","volume":"67","author":"Hirschfield","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jtauto.2026.100366_bib32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/labmed-2023-0127","article-title":"Diagnostic value of anti-hexokinase 1 and anti-kelch-like 12 antibodies in primary biliary cholangitis patients","volume":"48","author":"Yang","year":"2024","journal-title":"J. Lab. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib33","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/hep.21828","article-title":"Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis","volume":"46","author":"Leung","year":"2007","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jtauto.2026.100366_bib34","first-page":"206","article-title":"Antimitochondrial antibodies and their significance in diffuse and limited scleroderma","volume":"5","author":"Pope","year":"1999","journal-title":"J. Clin. Rheumatol. Pract. Rep. Rheum. Musculoskelet. Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ijd.15225","article-title":"Prevalence of antimitochondrial antibodies in subacute cutaneous lupus erythematosus","volume":"60","author":"Pelka","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib36","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/hep4.2067","article-title":"The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti-mitochondrial antibodies but without baseline PBC","volume":"6","author":"Duan","year":"2022","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jtauto.2026.100366_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1196\/annals.1398.024","article-title":"Comparison of two ELISA assays for anti-Sp100 determination","volume":"1109","author":"Manuel Lucena","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jtauto.2026.100366_bib38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2478\/jtim-2021-0008","article-title":"Promyelocytic leukemia antigen expression: a histological marker for primary biliary cholangitis diagnosis?","volume":"9","author":"Papamichalis","year":"2021","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib39","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/00365520310004876","article-title":"Clinical significance of anti-multiple nuclear dots\/Sp100 autoantibodies","volume":"38","author":"Wichmann","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib40","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10067-009-1359-9","article-title":"Primary Sjogren's syndrome with anticentromere antibodies--a clinically distinct subset","volume":"29","author":"Gulati","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib41","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1515\/cclm-2019-0655","article-title":"Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients","volume":"58","author":"Florin","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1177\/23971983231155948","article-title":"Systemic sclerosis and primary biliary cholangitis: longitudinal data to determine the outcomes","volume":"8","author":"Lepri","year":"2023","journal-title":"J. Scleroderma Relat. Disord."},{"key":"10.1016\/j.jtauto.2026.100366_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2567.2005.02197.x","article-title":"Identification of specific autoantigens in Sj\u00f6gren\u2019s syndrome by SEREX","volume":"116","author":"Uchida","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.jtauto.2026.100366_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841126","article-title":"Autoantibodies against proteins previously associated with autoimmunity in adult and pediatric patients with COVID-19 and children with MIS-C","volume":"13","author":"Burbelo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100366_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.869018","article-title":"Anti-mitochondrial antibody titers decrease over time in primary biliary cholangitis patients with ursodeoxycholic acid therapeutic response: a cohort study followed up to 28 years","volume":"13","author":"Chang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100366_bib46","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/0016-5085(90)90488-M","article-title":"Primary biliary cirrhosis","volume":"99","author":"Heseltine","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2026.100366_bib47","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0016-5085(80)90571-5","article-title":"Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients","volume":"78","author":"Christensen","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2026.100366_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-008-0150-6","article-title":"The value of antinuclear antibodies in primary biliary cirrhosis","volume":"8","author":"Gao","year":"2008","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib49","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.dld.2024.12.024","article-title":"The prognostic value of anti-gp210 and anti-centromere antibodies in patients with primary biliary cholangitis: enhancing the prognostic utility on the GLOBE scoring system","volume":"57","author":"Ding","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib50","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis","volume":"37","author":"Liberal","year":"2013","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib51","article-title":"Dissecting causal relationships between primary biliary cholangitis and extrahepatic autoimmune diseases based on Mendelian randomization","volume":"14","author":"Ma","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jtauto.2026.100366_bib52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10157-012-0724-1","article-title":"Anti-centromere antibody is an independent risk factor for chronic kidney disease in patients with primary biliary cirrhosis","volume":"17","author":"Mandai","year":"2013","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jtauto.2026.100366_bib53","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3748\/wjg.v19.i7.1111","article-title":"Risk factors for hepatic decompensation in patients with primary biliary cirrhosis","volume":"19","author":"Shi","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib54","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1542-3565(04)00465-3","article-title":"Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?","volume":"2","author":"Yang","year":"2004","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib55","first-page":"535","article-title":"Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis","volume":"41","author":"Haldar","year":"2021","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jtauto.2026.100366_bib56","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/hepr.12423","article-title":"Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2015","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib57","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clinre.2020.03.026","article-title":"Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators","volume":"44","author":"Qian","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib58","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.dld.2021.10.011","article-title":"The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China","volume":"54","author":"Chen","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib59","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.13927","article-title":"The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210","volume":"45","author":"Yang","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jtauto.2026.100366_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9121207","article-title":"Early prognostic utility of Gp210 antibody-positive rate in primary biliary cholangitis: a meta-analysis","volume":"2019","author":"Huang","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jtauto.2026.100366_bib61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2005-916321","article-title":"Antinuclear antibodies in primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"2005","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2024.100239","article-title":"Autoantibodes to GP210 are a metric for UDCA responses in primary biliary cholangitis","volume":"8","author":"Wang","year":"2024","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100366_bib63","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/biomedicines10040801","article-title":"Diagnostic and clinical value of specific autoantibodies against kelch-like 12 peptide and nuclear envelope proteins in patients with primary biliary cholangitis","volume":"10","author":"Bauer","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtauto.2026.100366_bib64","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1309\/AJCPQV4A7QAEEFEV","article-title":"The significance of autoantibody changes over time in primary biliary cirrhosis","volume":"144","author":"Tana","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jtauto.2026.100366_bib65","first-page":"2741","article-title":"PBC specific ANAs and UDCA response","volume":"7","author":"Sturrock","year":"2018","journal-title":"J. Gastroenterol. Hepatol. Res."},{"key":"10.1016\/j.jtauto.2026.100366_bib66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/diagnostics11040587","article-title":"Analysis of autoantibodies against promyelocytic leukemia nuclear body components and biochemical parameters in sera of patients with primary biliary cholangitis","volume":"11","author":"Bauer","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.jtauto.2026.100366_bib67","first-page":"1123","article-title":"Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis","volume":"26","author":"Z\u00fcchner","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib68","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.32117","article-title":"Primary biliary cholangitis: 2021 practice guidance update from the American association for the study of liver diseases","volume":"75","author":"Lindor","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib69","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12026-016-8838-2","article-title":"Diagnostic accuracy of two tests for determination of anti-m2 in the diagnosis of primary biliary cirrhosis: is it possible to predict the course of the disease?","volume":"65","author":"Alfano","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jtauto.2026.100366_bib70","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10875-007-9092-0","article-title":"Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis","volume":"27","author":"Gabeta","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jtauto.2026.100366_bib71","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3109\/08916934.2013.801461","article-title":"Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease","volume":"46","author":"Gatselis","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jtauto.2026.100366_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.1161","article-title":"Clinical performance of AMA\u2010M2, anti\u2010gp210 and anti\u2010sp100 antibody levels in primary biliary cholangitis: when detected by multiplex bead\u2010based flow fluorescent immunoassay","volume":"12","author":"Wang","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib73","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12072-012-9413-0","article-title":"Humoral autoimmune response heterogeneity in the spectrum of primary biliary cirrhosis","volume":"7","author":"Dellavance","year":"2013","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jtauto.2026.100366_bib74","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1053\/j.gastro.2022.08.054","article-title":"Greater transplant-free survival in patients receiving obeticholic acid for primary biliary cholangitis in a clinical trial setting compared to real-world external controls","volume":"163","author":"Murillo Perez","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2026.100366_bib75","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib76","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaut.2005.10.007","article-title":"Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis","volume":"26","author":"Nakamura","year":"2006","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100366_bib77","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.cca.2012.03.020","article-title":"Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis","volume":"413","author":"Mytilinaiou","year":"2012","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.jtauto.2026.100366_bib78","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1440-1746.1995.tb01597.x","article-title":"High prevalence of antibodies to recombinant CENP\u2010B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities","volume":"10","author":"Parveen","year":"1995","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib79","doi-asserted-by":"crossref","DOI":"10.17235\/reed.2020.7483\/2020","article-title":"Detection of anti-kelch-like 12 and anti-hexokinase 1 antibodies in primary biliary cholangitis patients in China","author":"Bin","year":"2020","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.jtauto.2026.100366_bib80","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.24630","article-title":"Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis","volume":"55","author":"Lleo","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib81","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0168-8278(99)80098-1","article-title":"Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis","volume":"30","author":"Poupon","year":"1999","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib82","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1478-3231.2004.0918.x","article-title":"Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA\u2010treated patients with primary biliary cirrhosis","volume":"24","author":"Corpechot","year":"2004","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100366_bib83","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2026.100366_bib84","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hep.26322","article-title":"Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study","volume":"58","author":"Zhang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib85","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2026.100366_bib86","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.28017","article-title":"The UK\u2010PBC risk scores: derivation and validation of a scoring system for long\u2010term prediction of end\u2010stage liver disease in primary biliary cholangitis","volume":"63","author":"Carbone","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib87","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12072-017-9819-9","article-title":"A brief review on prognostic models of primary biliary cholangitis","volume":"11","author":"Chen","year":"2017","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jtauto.2026.100366_bib88","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.14309\/ajg.0000000000000290","article-title":"Validation of risk scoring systems in ursodeoxycholic acid\u2013treated patients with primary biliary cholangitis","volume":"114","author":"Efe","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib89","doi-asserted-by":"crossref","DOI":"10.20524\/aog.2025.0953","article-title":"Primary biliary cholangitis: a summary of pathogenesis and therapies","author":"Jallouli","year":"2025","journal-title":"Ann. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib90","article-title":"Pretransplant evaluation and liver transplantation outcome in PBC patients","volume":"2022","author":"Mijic","year":"2022","journal-title":"Chin. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib91","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"The UDCA\u2013PBC study group\u2217, A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis","volume":"324","author":"Poupon","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib92","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/jgh.13534","article-title":"Evidence for the association between IgG\u2010antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis","volume":"32","author":"Tang","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib93","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00196579","article-title":"Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis","volume":"74","author":"Kisand","year":"1996","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib94","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/1098-2825(2000)14:5<208::AID-JCLA2>3.0.CO;2-6","article-title":"Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis","volume":"14","author":"Hazama","year":"2000","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.jtauto.2026.100366_bib95","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10446670410001722113","article-title":"Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis","volume":"11","author":"Benson","year":"2004","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.jtauto.2026.100366_bib96","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1872-034X.2008.00474.x","article-title":"Ursodeoxycholic acid reduces CpG\u2010induced IgM production in patients with primary biliary cirrhosis","volume":"39","author":"Kikuchi","year":"2009","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.jtauto.2026.100366_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242164","article-title":"Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: a single center study from China","volume":"15","author":"Feng","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2026.100366_bib98","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510250103","article-title":"Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression","volume":"25","author":"Van Norstrand","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib99","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.3748\/wjg.v18.i30.3938","article-title":"B cell depletion in treating primary biliary cirrhosis: pros and cons","volume":"18","author":"Yin","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib100","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3748\/wjg.v10.i6.894","article-title":"Fenofibrate for patients with asymptomatic primary biliary cirrhosis","volume":"10","author":"Dohmen","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib101","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/hep.21172","article-title":"Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis","volume":"43","author":"Wesierska-Gadek","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib102","first-page":"684","article-title":"Factors associated with progression and outcomes of early stage primary biliary cholangitis","volume":"18","author":"Gatselis","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"10.1016\/j.jtauto.2026.100366_bib103","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1007\/s10067-021-05657-z","article-title":"The clinical and laboratory features associated with cancer in patients with primary biliary cholangitis: a longitudinal survey-based study","volume":"40","author":"Bian","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib104","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/hep.25788","article-title":"Primary biliary cirrhosis and cancer risk: a systematic review and meta-analysis","volume":"56","author":"Liang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2019.104021","article-title":"Recurrence of disease following organ transplantation in autoimmune liver disease and systemic lupus erythematosus","volume":"347","author":"Tanaka","year":"2020","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jtauto.2026.100366_bib106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/cclm-2017-0249","article-title":"The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: a review of literature","volume":"56","author":"De Liso","year":"2017","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.jtauto.2026.100366_bib107","first-page":"384","article-title":"Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis","volume":"42","author":"John","year":"2022","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jtauto.2026.100366_bib108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1478-3231.2007.01651.x","article-title":"Antimitochondrial antibody\u2010negative primary biliary cirrhosis: a subset of primary biliary cirrhosis","volume":"28","author":"Liu","year":"2008","journal-title":"Liver Int."},{"key":"10.1016\/j.jtauto.2026.100366_bib109","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1007\/s10620-021-07122-y","article-title":"Members of the Brazilian cholestasis study group consortium, anti-mitochondrial antibody-negative primary biliary cholangitis is part of the same spectrum of classical primary biliary cholangitis","volume":"67","author":"Can\u00e7ado","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jtauto.2026.100366_bib110","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12876-025-04280-5","article-title":"Comparison of pathological features of patients with antibody-negative and positive primary biliary cholangitis","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib111","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/gut.35.2.260","article-title":"Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis","volume":"35","author":"Michieletti","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.jtauto.2026.100366_bib112","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s005350050380","article-title":"Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis?","volume":"34","author":"Nakajima","year":"1999","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib113","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3109\/00365521.2015.1132337","article-title":"Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis","volume":"51","author":"Juliusson","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib114","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.25511","article-title":"Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis","volume":"55","author":"Jin","year":"2012","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jtauto.2026.100366_bib116","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jtauto.2026.100366_bib117","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/joim.13005","article-title":"Low rate of new-onset primary biliary cholangitis in a cohort of anti-mitochondrial antibody-positive subjects over six years of follow-up","volume":"287","author":"Zandanell","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib118","first-page":"69","article-title":"The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients","volume":"4","author":"Ergenc","year":"2023","journal-title":"Hepatol. Forum"},{"key":"10.1016\/j.jtauto.2026.100366_bib119","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3350\/cmh.2024.0416","article-title":"Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive","volume":"31","author":"Li","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib120","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/hep.1840060609","article-title":"Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?","volume":"6","author":"Mitchison","year":"1986","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jtauto.2026.100366_bib121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2019.01.005","article-title":"Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: is alkaline phosphatase truly a surrogate marker?","volume":"99","author":"Sun","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100366_bib122","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/hepr.12809","article-title":"Positive antimitochondrial antibody but normal serum alkaline phosphatase levels: could it be primary biliary cholangitis?","volume":"47","author":"Berdichevski","year":"2017","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib123","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jhep.2010.02.019","article-title":"Demographic, lifestyle, medical and familial factors associated with primary biliary cirrhosis","volume":"53","author":"Corpechot","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jtauto.2026.100366_bib124","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jtauto.2026.100366_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240794","article-title":"Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases","volume":"15","author":"Thomsen","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2026.100366_bib126","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.29675","article-title":"Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis","volume":"68","author":"\u00d6rnolfsson","year":"2018","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.jtauto.2026.100366_bib127","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.21749","article-title":"Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis","volume":"46","author":"Lazaridis","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib128","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.3748\/wjg.v18.i34.4721","article-title":"Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients","volume":"18","author":"Zografos","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib129","first-page":"1378","article-title":"Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up","volume":"36","author":"Gulamhusein","year":"2016","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"10.1016\/j.jtauto.2026.100366_bib130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.gastro.2004.05.005","article-title":"Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment","volume":"127","author":"Selmi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtauto.2026.100366_bib131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/cld.308","article-title":"Primary biliary cirrhosis: family, genes, and bugs","volume":"3","author":"Mells","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib132","article-title":"Primary biliary cirrhosis: family stories","volume":"2011","author":"Smyk","year":"2011","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib133","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00005-019-00550-9","article-title":"Variant and specific forms of autoimmune cholestatic liver diseases","volume":"67","author":"Dalekos","year":"2019","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.jtauto.2026.100366_bib134","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaut.2010.09.005","article-title":"PBC screen: an IgG\/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis","volume":"35","author":"Liu","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100366_bib135","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dld.2004.09.019","article-title":"The Western immunoblotting pattern of anti-mitochondrial antibodies is independent of the clinical expression of primary biliary cirrhosis","volume":"37","author":"Muratori","year":"2005","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib136","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1515\/cclm-2018-0807","article-title":"Standardization and harmonization of autoimmune diagnostics","volume":"56","author":"Jacobs","year":"2018","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.jtauto.2026.100366_bib137","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1515\/cclm-2025-1030","article-title":"Towards harmonization of autoantibody detection in relation to paraneoplastic neurological syndromes (PNS): a European survey on laboratory practices","volume":"64","author":"Oyaert","year":"2026","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.jtauto.2026.100366_bib138","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1515\/cclm-2017-1077","article-title":"Standardization of autoimmune testing \u2013 is it feasible?","volume":"56","author":"Monogioudi","year":"2018","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.jtauto.2026.100366_bib139","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s12016-016-8579-y","article-title":"Challenges in the standardization of autoantibody testing: a comprehensive review","volume":"53","author":"Tozzoli","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jtauto.2026.100366_bib140","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/annrheumdis-2020-217416","article-title":"Standardisation of PR3-ANCA and MPO-ANCA: evaluation of certified reference materials","volume":"79","author":"Bossuyt","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2026.100366_bib141","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1515\/cclm-2025-0032","article-title":"Antiphospholipid IgG certified reference material ERM\u00ae -DA477\/IFCC: a tool for aPL harmonization?","volume":"63","author":"Grossi","year":"2025","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.jtauto.2026.100366_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2025.113903","article-title":"Development of a chimeric monoclonal antibody as a potential diagnostic reference in PR3-ANCA detection","volume":"542","author":"Zhang","year":"2025","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jtauto.2026.100366_bib143","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13317-020-0127-3","article-title":"The perspective on standardisation and harmonisation: the viewpoint of the EASI president","volume":"11","author":"Damoiseaux","year":"2020","journal-title":"Autoimmun. Highlights"},{"key":"10.1016\/j.jtauto.2026.100366_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103608","article-title":"Reflecting on a decade of the international consensus on ANA patterns (ICAP): accomplishments and challenges from the perspective of the 7th ICAP workshop","volume":"23","author":"Andrade","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2026.100366_bib145","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1515\/cclm-2023-0209","article-title":"Detection of antinuclear antibodies: recommendations from EFLM, EASI and ICAP","volume":"61","author":"Bonroy","year":"2023","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.jtauto.2026.100366_bib146","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/clinchem\/hvad222","article-title":"Reporting likelihood ratio in autoimmune serology: just a theory or feasible in practice?","volume":"70","author":"Bossuyt","year":"2024","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jtauto.2026.100366_bib147","first-page":"1","article-title":"Meta-analysis of antinuclear antibodies in the diagnosis of antimitochondrial antibody-negative primary biliary cholangitis","volume":"2019","author":"Zhang","year":"2019","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.jtauto.2026.100366_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2023.100188","article-title":"PPAR agonists for the treatment of primary biliary cholangitis: old and new tales","volume":"6","author":"Colapietro","year":"2023","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.jtauto.2026.100366_bib149","doi-asserted-by":"crossref","first-page":"8503","DOI":"10.3390\/jcm14238503","article-title":"Autoantibodies in primary biliary cholangitis: from classical markers to emerging targets","volume":"14","author":"Mimura","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jtauto.2026.100366_bib150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bpg.2018.06.002","article-title":"Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC)","volume":"34\u201335","author":"Janmohamed","year":"2018","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jtauto.2026.100366_bib151","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.autrev.2013.10.015","article-title":"Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems","volume":"13","author":"Bizzaro","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jtauto.2026.100366_bib152","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13317-012-0035-2","article-title":"Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory","volume":"3","author":"Tozzoli","year":"2012","journal-title":"Autoimmun. Highlights"},{"key":"10.1016\/j.jtauto.2026.100366_bib153","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2020.09.031","article-title":"Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: computer-aided versus conventional microscopic evaluation of routine diagnostic samples from patients with vasculitis or other inflammatory diseases","volume":"511","author":"Nagy","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jtauto.2026.100366_bib154","article-title":"Multiparametric autoimmune diagnostics: recent advances","volume":"15","author":"Damoiseaux","year":"2016","journal-title":"Pathol. Lab. Med. Int."},{"key":"10.1016\/j.jtauto.2026.100366_bib155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jim.2017.05.003","article-title":"Multiplex autoantibody detection for autoimmune liver diseases and autoimmune gastritis","volume":"448","author":"Vanderlocht","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jtauto.2026.100366_bib156","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1515\/cclm-2020-0122","article-title":"Evaluation of a novel extended automated particle-based multi-analyte assay for the detection of autoantibodies in the diagnosis of primary biliary cholangitis","volume":"58","author":"Villalta","year":"2020","journal-title":"Clin. Chem. Lab. Med. CCLM"},{"key":"10.1016\/j.jtauto.2026.100366_bib157","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.21583","article-title":"A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis","volume":"45","author":"Oertelt","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jtauto.2026.100366_bib158","article-title":"Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: a real-world retrospective study of 537 patients in China","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:24:01Z","timestamp":1781659441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909026000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":157,"alternative-id":["S2589909026000195"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100366","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in the diagnostics, prognostics and follow-up of primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100366"}}